US officials back loosening testosterone prescribing rules as medical necessity remains low
Juste les faits

US officials back loosening testosterone prescribing rules as medical necessity remains low

Résumé

The FDA is proposing label changes that would expand testosterone use for age-related symptoms, while research shows only about 12% of current prescriptions meet strict medical criteria.

Washington is moving to ease restrictions on testosterone therapy after the Food and Drug Administration announced a proposal to rewrite prescribing instructions. The draft would allow the hormone to be used for age-related symptoms such as low libido and erectile dysfunction, expanding beyond its current label that limits use to men with clinically low testosterone caused by serious medical conditions or injury.

Health Secretary Robert F. Kennedy Jr. and other senior officials have voiced support for the change, echoing advice from online health influencers who promote testosterone for muscle gain and energy. Defense Secretary Pete Hegseth said the Pentagon will start screening service members for low testosterone and offer treatment to help troops perform at their "absolute best."

Medical experts caution that the majority of prescriptions do not meet the strict criteria outlined in recent guidelines. Dr. Helen Bernie, a urologist at Indiana University, said most patients she sees are men seeking relief from common symptoms that affect quality of life. Dr. Shalender Bhasin of Harvard Medical School, a co-author of the Endocrine Society’s current guidelines, noted that only 12% of men receiving testosterone prescriptions had documented low hormone levels confirmed by two blood tests.

The FDA removed a boxed warning about heart risks in 2022 after a study of 5,000 men with prior heart disease found no increase in cardiovascular events with testosterone gel. Subsequent NIH studies of nearly 800 older men reported improvements in erectile function and libido, with minimal effects on fatigue, memory or overall well-being. Bhasin called the label revisions "very welcome" but said longer-term studies are still needed to assess safety, including potential links to prostate cancer.

Experts warn that testosterone can suppress natural hormone production and sperm formation, making it unsuitable for men planning to father children. They also advise caution with online supplement claims and telehealth providers, noting that many do not require basic screening or confirm low testosterone levels before prescribing the drug.

Source

Fortune

Continuez à lire — gratuitement

Créez un compte gratuit pour suivre l'actualité. Aucune carte requise.